M11.15 Familial chondrocalcinosis, hip

Name of the Condition

• Familial chondrocalcinosis, hip

Summary

Familial chondrocalcinosis, hip is a hereditary condition characterized by the deposition of calcium pyrophosphate dihydrate (CPPD) crystals in the hip joint and surrounding tissues. This leads to inflammation, pain, and potential joint damage. It is part of the broader group of crystal arthropathies and is distinguished by its familial inheritance pattern and hip-specific involvement. Diagnosis typically involves clinical evaluation, imaging, and sometimes crystal identification in joint fluid or tissue.

Causes

Familial chondrocalcinosis, hip is caused by genetic mutations that influence calcium pyrophosphate crystal formation in the hip’s cartilage, synovium, or periarticular structures. These mutations may affect enzymes or proteins involved in crystal metabolism, leading to abnormal crystal deposition. The condition is inherited, though the exact genetic pathways vary.

Risk Factors

• Family history of chondrocalcinosis or related crystal arthropathies.
• Advanced age (increases likelihood of crystal deposition).
• Metabolic conditions affecting calcium or phosphate levels.
• Hip trauma or surgery (may trigger crystal release).
• Chronic inflammatory joint diseases.

Symptoms

• Hip pain, swelling, and stiffness.
• Recurrent episodes of acute inflammation.
• Reduced range of motion in the hip joint.
• Morning stiffness that improves with activity.

Diagnosis

Diagnosis of familial chondrocalcinosis, hip involves a combination of clinical assessment, imaging studies (e.g., X-rays, ultrasound, or MRI to detect crystal deposits or joint damage), and sometimes analysis of joint fluid to identify CPPD crystals. Family history and genetic testing may also support the diagnosis, particularly in cases with a known hereditary pattern.

Treatment Options

Treatment focuses on managing symptoms and preventing joint damage. Nonsteroidal anti-inflammatory drugs (NSAIDs) or colchicine may reduce inflammation during acute episodes. Intra-articular corticosteroid injections can provide targeted relief for severe pain. Physical therapy helps maintain joint function, while disease-modifying therapies (e.g., targeting crystal formation) are under investigation. Surgical intervention, such as hip replacement, may be considered for advanced joint damage.

Prognosis and Follow-Up

The prognosis varies depending on the extent of joint damage and response to treatment. Early diagnosis and management can help preserve hip function and reduce complications. Regular follow-up with a healthcare provider is recommended to monitor symptoms, adjust treatment, and address any progressive joint damage. Long-term outcomes may include chronic pain or reduced mobility if untreated.

Complications

Potential complications include chronic hip pain, progressive joint degeneration (osteoarthritis), reduced mobility, and functional impairment. Recurrent acute episodes may lead to joint deformity or disability over time. In rare cases, crystal deposition in other joints or tissues may occur.

Lifestyle & Prevention

Lifestyle modifications, such as maintaining a healthy weight to reduce hip stress, engaging in low-impact exercise (e.g., swimming or cycling), and avoiding activities that strain the hip, may help manage symptoms. Protecting the hip from injury and managing underlying metabolic conditions (if present) can also support joint health. Genetic counseling may be beneficial for families with a history of the condition.

When to Seek Professional Help

Seek medical attention if you experience persistent hip pain, swelling, or stiffness that interferes with daily activities. Acute episodes of severe pain, fever, or inability to bear weight on the hip require prompt evaluation. Regular check-ups are advised for individuals with a family history of chondrocalcinosis to monitor for early signs of joint involvement.

Tips for Medical Coders

When coding for familial chondrocalcinosis, hip (M11.15), ensure documentation specifies the hip as the site of involvement and confirms the hereditary nature of the condition. Include details about clinical findings, imaging results, or crystal identification to support the diagnosis. Verify that the code aligns with the patient’s documented history and presentation, as specificity to the hip site is critical for accurate coding.